2025-04-13 - Analysis Report
## Costco Wholesale Corp (COST) Stock Review

**0. Key Figures Summary:**

* **Cumulative Return (COST):** 287.17%
* **Cumulative Return (VOO):** 66.36%
* **Return Difference (COST vs. VOO):** 220.8% (97.5% percentile relative to historical range)
* **Current Price:** $963.41
* **Expected Return (vs. S&P 500):** 28.4% (long-term, 2+ years)


**1. Company Overview & Performance Comparison:**

Costco Wholesale Corp is a membership-only warehouse club operating globally, known for its bulk discounts and a wide range of products.  The provided data shows that COST significantly outperformed the S&P 500 (VOO) over the analyzed period.  The cumulative return of COST is 220.8 percentage points higher than VOO, placing it at the 97.5th percentile of its historical performance relative to the S&P 500. This indicates a substantial outperformance.

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 27.0% | 55.6% | -2.0% | 0.1 | 74.3 |
| 2016-2018  | 16.0% | 61.5% | -2.0% | 0.2 | 82.2 |
| 2017-2019  | 54.0% | 61.5% | 25.0% | 0.4 | 119.7 |
| 2018-2020  | 67.0% | 80.0% | 42.0% | 0.2 | 158.8 |
| 2019-2021  | 138.0% | 80.0% | 84.0% | 0.2 | 241.1 |
| 2020-2022  | 81.0% | 80.0% | 75.0% | 0.2 | 195.2 |
| 2021-2023  | 134.0% | 71.2% | 117.0% | 0.5 | 290.8 |
| 2022-2024  | 128.0% | 81.0% | 111.0% | 0.4 | 406.1 |
| 2023-2025  | 117.0% | 81.0% | 103.0% | 0.4 | 427.4 |

The table shows consistently high CAGR (Compound Annual Growth Rate), indicating strong historical performance.  Alpha values are generally positive, suggesting outperformance relative to the market benchmark, though they fluctuate. Beta values are generally low, indicating lower volatility than the overall market.  Market capitalization has shown steady growth.


**2. Recent Price Movement:**

* **Closing Price:** $963.41
* **Previous Close:** $964.31
* **5-Day Moving Average:** $941.96
* **20-Day Moving Average:** $931.82
* **60-Day Moving Average:** $978.25

The closing price is slightly below the previous close, indicating a minor decrease.  The price is below the 60-day moving average but above the 5-day and 20-day moving averages, suggesting a potential short-term downward trend but longer-term support.


**3. Technical Indicators & Expected Return:**

* **Market Risk Indicator (MRI):** 0.47 (High Risk) – Indicates a relatively high level of risk.
* **RSI:** 60.49 – Suggests the stock is neither overbought nor oversold, indicating a neutral sentiment.
* **PPO:** 0.66 – A positive PPO suggests bullish momentum.
* **20-Day Relative Divergence Change:** +3.7 – Indicates a recent short-term upward trend.
* **Expected Return (vs S&P 500):** 28.4% (long-term).  This is a significant expected outperformance.

The small price drop (-$0.09) doesn't indicate a significant event, such as a sudden jump or drop.


**4. Recent Earnings Analysis:**

| 날짜       | EPS    | 매출 (B$) |
|------------|--------|-----------|
| 2025-03-13 | 4.03   | 63.72     |
| 2024-12-19 | 4.05   | 62.15     |
| 2024-06-06 | 3.79   | 58.52     |
| 2024-03-13 | 3.93   | 58.44     |
| 2024-03-13 | 3.93   | 58.44     | *(Duplicate Entry)*


Earnings show relatively stable EPS, with some minor fluctuations.  Revenue also shows stability, although there's a higher revenue figure in Q2 2024. The duplicated entry needs clarification.


**5. Financial Information:**

**Revenue and Profitability:**

| Quarter     | Revenue (B$) | Profit Margin |
|-------------|---------------|---------------|
| 2025-02-28  | $63.72        | 12.52%        |
| 2024-11-30  | $62.15        | 12.94%        |
| 2024-08-31  | $79.70        | 12.68%        |
| 2024-05-31  | $58.52        | 12.55%        |
| 2024-02-29  | $58.44        | 12.49%        |

Revenue fluctuates but shows general stability;  profit margins are consistently around 12.5%, showing healthy profitability. The high revenue in Q2 2024 requires further investigation to understand the underlying drivers.

**Capital and Profitability:**

| Quarter     | Equity (B$) | ROE (%) |
|-------------|--------------|---------|
| 2025-02-28  | $25.58       | 6.99    |
| 2024-11-30  | $24.45       | 7.35    |
| 2024-08-31  | $23.62       | 9.97    |
| 2024-05-31  | $21.77       | 7.72    |
| 2024-02-29  | $20.76       | 8.40    |

Equity shows steady growth, indicating a healthy financial position. ROE (Return on Equity) is generally good, with a notable peak in Q2 2024, suggesting strong efficiency during that period.


**6. Overall Analysis:**

COST has demonstrated significantly strong historical performance, consistently outperforming the S&P 500.  While the MRI indicates high risk, the relatively stable financial metrics, healthy profit margins, and strong revenue suggest underlying strength. The recent slight price dip might be a minor correction within a generally upward trend.  The high expected return, supported by historical data, suggests that a long-term investment strategy could be favorable, particularly given the company's strong financial fundamentals. However, further investigation into the reasons for the high revenue in Q2 2024 and the duplicated earnings entry is recommended before making any investment decision.  The high MRI should be considered when assessing overall risk tolerance.
